This news release contains forward-looking statements relating to the common shares of the Company being posted for trading on the OTCQB and other statements that are not historical facts. To learn more about how we create better informed and more efficient markets, visit Contact InformationĮmail: the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 11,000 U.S. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process, including meeting a minimum bid price and other financial conditions. and international companies that may not yet qualify for OTCQX. The OTCQB offers investors transparent trading in entrepreneurial and development stage U.S. "Having the Company's common shares posted for trading on the OTCQB and providing a more efficient way of trading our shares will be an important milestone in our strategy of building awareness and enhancing accessibility amongst United States investors looking for exposure to the growth potential of Novamind's mental health and psychedelic medicine business," said Yaron Conforti, CEO and Director of Novamind. The Company currently trades and will continue to trade on the Canadian Securities Exchange ("CSE") under its existing symbol "NM" and on the Frankfurt Stock Exchange ("FSE") under its existing symbol "HN2". and the satisfaction of applicable eligibility requirements. The posting of the Company's common shares for trading on the OTCQB remains subject to the approval of the OTC Markets Group, Inc. The Company has also applied for Depository Trust Company (DTC) eligibility which would greatly simplify the process of trading the Company's common shares. trading platform operated by the OTC Markets Group, Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has submitted its application to have its common shares posted for trading on the OTCQB® Venture Market (the "OTCQB"), a U.S. TORONTO, ON / ACCESSWIRE / J/ Novamind Inc. Aims to increase visibility and facilitate investment for United States investors
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |